# Tier 5 Enumeration: Endocrine & Other Medications

> **Location in Hierarchy**:
> Tier 1: Medical > Tier 2: Medications > Tier 3: Prescription Medications > Tier 4: Endocrine/Other Medications > **Tier 5: Individual Cards**

---

## Overview

This document enumerates ALL individual Tier 5 cards for Endocrine and Other miscellaneous prescription medications. Each entry represents ONE SMART card with titratable doses handled within a single card.

**Total Estimated Cards**: ~75 cards

---

## THYROID MEDICATIONS

### Tier 4: Hypothyroid Agents

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_THY_001 | Levothyroxine (Synthroid, Levoxyl) | 25-200mcg daily | Hypothyroidism |
| MED_ENDO_THY_002 | Liothyronine (Cytomel) | 5-50mcg daily | Hypothyroidism (T3), Myxedema |
| MED_ENDO_THY_003 | Desiccated Thyroid (Armour Thyroid) | 30-180mg daily | Hypothyroidism (T3+T4 natural) |
| MED_ENDO_THY_004 | Liotrix (Thyrolar) | 30-180mcg daily | Hypothyroidism (T3+T4 synthetic) |

**Subtotal: 4 cards**

---

### Tier 4: Hyperthyroid Agents

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_HYPER_001 | Methimazole (Tapazole) | 5-30mg daily | Hyperthyroidism, Graves' disease |
| MED_ENDO_HYPER_002 | Propylthiouracil (PTU) | 50-150mg TID | Hyperthyroidism (pregnancy 1st tri) |

**Subtotal: 2 cards**

---

## BONE HEALTH MEDICATIONS

### Tier 4: Bisphosphonates

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_BONE_001 | Alendronate (Fosamax) | 10mg daily or 70mg weekly | Osteoporosis |
| MED_ENDO_BONE_002 | Risedronate (Actonel) | 5mg daily or 35mg weekly or 150mg monthly | Osteoporosis |
| MED_ENDO_BONE_003 | Ibandronate (Boniva) | 150mg monthly or 3mg IV q3mo | Osteoporosis |
| MED_ENDO_BONE_004 | Zoledronic Acid (Reclast) | 5mg IV yearly | Osteoporosis |

**Subtotal: 4 cards**

---

### Tier 4: Other Bone Agents

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_BONEOTH_001 | Denosumab (Prolia) | 60mg SQ q6months | Osteoporosis |
| MED_ENDO_BONEOTH_002 | Teriparatide (Forteo) | 20mcg SQ daily | Severe osteoporosis (anabolic) |
| MED_ENDO_BONEOTH_003 | Abaloparatide (Tymlos) | 80mcg SQ daily | Severe osteoporosis (anabolic) |
| MED_ENDO_BONEOTH_004 | Romosozumab (Evenity) | 210mg SQ monthly x 12 | Severe osteoporosis |
| MED_ENDO_BONEOTH_005 | Raloxifene (Evista) | 60mg daily | Osteoporosis (postmenopausal), Breast CA risk |
| MED_ENDO_BONEOTH_006 | Calcitonin Salmon (Miacalcin) | 200 IU intranasal daily | Osteoporosis (limited use) |

**Subtotal: 6 cards**

---

## CORTICOSTEROIDS

### Tier 4: Systemic Corticosteroids

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_STEROID_001 | Prednisone | 5-60mg daily | Inflammation, Autoimmune, Asthma exacerbation |
| MED_ENDO_STEROID_002 | Prednisolone | 5-60mg daily | Same as prednisone (liquid available) |
| MED_ENDO_STEROID_003 | Methylprednisolone (Medrol) | 4-48mg daily or dose pack | Inflammation, MS, Spinal cord injury |
| MED_ENDO_STEROID_004 | Dexamethasone | 0.5-10mg daily | Cerebral edema, N/V, COVID, Croup |
| MED_ENDO_STEROID_005 | Hydrocortisone | 20-240mg daily | Adrenal insufficiency, Stress dosing |
| MED_ENDO_STEROID_006 | Fludrocortisone (Florinef) | 0.05-0.2mg daily | Adrenal insufficiency (mineralocorticoid) |
| MED_ENDO_STEROID_007 | Budesonide (Entocort) | 9mg daily | IBD, Autoimmune hepatitis |

**Subtotal: 7 cards**

---

## ALLERGY MEDICATIONS

### Tier 4: Antihistamines (Rx)

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_ALLERGY_001 | Hydroxyzine (Vistaril, Atarax) | 25-100mg QID | Anxiety, Pruritus, Allergies |
| MED_ENDO_ALLERGY_002 | Promethazine (Phenergan) | 12.5-25mg q4-6h | Allergies, N/V, Motion sickness |
| MED_ENDO_ALLERGY_003 | Cyproheptadine (Periactin) | 4mg TID | Allergies, Appetite stimulant, Serotonin syndrome |

**Subtotal: 3 cards**

---

### Tier 4: Nasal Corticosteroids

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_NASAL_001 | Fluticasone Propionate Nasal (Flonase) | 1-2 sprays each nostril daily | Allergic rhinitis |
| MED_ENDO_NASAL_002 | Mometasone Nasal (Nasonex) | 2 sprays each nostril daily | Allergic rhinitis, Nasal polyps |
| MED_ENDO_NASAL_003 | Triamcinolone Nasal (Nasacort) | 2 sprays each nostril daily | Allergic rhinitis |
| MED_ENDO_NASAL_004 | Budesonide Nasal (Rhinocort) | 1-4 sprays each nostril daily | Allergic rhinitis |
| MED_ENDO_NASAL_005 | Fluticasone Furoate (Veramyst) | 1-2 sprays each nostril daily | Allergic rhinitis |
| MED_ENDO_NASAL_006 | Azelastine Nasal (Astelin) | 1-2 sprays each nostril BID | Allergic/Vasomotor rhinitis |
| MED_ENDO_NASAL_007 | Azelastine/Fluticasone (Dymista) | 1 spray each nostril BID | Allergic rhinitis |

**Subtotal: 7 cards**

---

## RHEUMATOLOGIC/IMMUNOLOGIC MEDICATIONS

### Tier 4: DMARDs (Disease-Modifying Antirheumatic Drugs)

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_DMARD_001 | Methotrexate | 7.5-25mg weekly | RA, Psoriasis, Ectopic pregnancy |
| MED_ENDO_DMARD_002 | Hydroxychloroquine (Plaquenil) | 200-400mg daily | SLE, RA, Sj√∂gren's |
| MED_ENDO_DMARD_003 | Sulfasalazine (Azulfidine) | 500-1500mg BID | RA, IBD |
| MED_ENDO_DMARD_004 | Leflunomide (Arava) | 10-20mg daily | RA |
| MED_ENDO_DMARD_005 | Apremilast (Otezla) | 30mg BID | Psoriatic arthritis, Psoriasis |
| MED_ENDO_DMARD_006 | Tofacitinib (Xeljanz) | 5-11mg daily | RA, UC, Psoriatic arthritis (JAK inhibitor) |
| MED_ENDO_DMARD_007 | Baricitinib (Olumiant) | 2mg daily | RA (JAK inhibitor) |
| MED_ENDO_DMARD_008 | Upadacitinib (Rinvoq) | 15mg daily | RA, Psoriatic arthritis, UC |

**Subtotal: 8 cards**

---

### Tier 4: Biologic DMARDs

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_BIODMARD_001 | Adalimumab (Humira) | 40mg SQ q2wks | RA, Psoriasis, IBD, AS |
| MED_ENDO_BIODMARD_002 | Etanercept (Enbrel) | 50mg SQ weekly | RA, Psoriasis, AS |
| MED_ENDO_BIODMARD_003 | Infliximab (Remicade) | 3-5mg/kg IV q8wks | RA, Psoriasis, IBD, AS |
| MED_ENDO_BIODMARD_004 | Certolizumab (Cimzia) | 200mg SQ q2wks | RA, Psoriasis, Crohn's |
| MED_ENDO_BIODMARD_005 | Golimumab (Simponi) | 50mg SQ monthly | RA, Psoriatic arthritis, AS, UC |
| MED_ENDO_BIODMARD_006 | Secukinumab (Cosentyx) | 150-300mg SQ q4wks | Psoriasis, Psoriatic arthritis, AS |
| MED_ENDO_BIODMARD_007 | Ixekizumab (Taltz) | 80mg SQ q4wks | Psoriasis, Psoriatic arthritis, AS |
| MED_ENDO_BIODMARD_008 | Ustekinumab (Stelara) | 45-90mg SQ q12wks | Psoriasis, Psoriatic arthritis, IBD |
| MED_ENDO_BIODMARD_009 | Abatacept (Orencia) | 125mg SQ weekly | RA |
| MED_ENDO_BIODMARD_010 | Rituximab (Rituxan) | 1000mg IV q2wks x 2 | RA (anti-CD20) |
| MED_ENDO_BIODMARD_011 | Tocilizumab (Actemra) | 162mg SQ weekly | RA (IL-6 inhibitor) |
| MED_ENDO_BIODMARD_012 | Sarilumab (Kevzara) | 200mg SQ q2wks | RA (IL-6 inhibitor) |

**Subtotal: 12 cards**

---

### Tier 4: Gout Medications

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_GOUT_001 | Allopurinol (Zyloprim) | 100-800mg daily | Gout (urate lowering) |
| MED_ENDO_GOUT_002 | Febuxostat (Uloric) | 40-80mg daily | Gout (urate lowering) |
| MED_ENDO_GOUT_003 | Colchicine (Colcrys) | 0.6mg daily-BID | Gout prophylaxis, Acute flare |
| MED_ENDO_GOUT_004 | Probenecid | 250-500mg BID | Gout (uricosuric) |
| MED_ENDO_GOUT_005 | Pegloticase (Krystexxa) | 8mg IV q2wks | Refractory gout |

**Subtotal: 5 cards**

---

## HORMONAL AGENTS

### Tier 4: Testosterone Replacement

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_TEST_001 | Testosterone Cypionate | 50-400mg IM q2-4wks | Male hypogonadism |
| MED_ENDO_TEST_002 | Testosterone Enanthate | 50-400mg IM q2-4wks | Male hypogonadism |
| MED_ENDO_TEST_003 | Testosterone Gel (AndroGel, Testim) | 50-100mg daily | Male hypogonadism |
| MED_ENDO_TEST_004 | Testosterone Patch (Androderm) | 2-4mg daily | Male hypogonadism |
| MED_ENDO_TEST_005 | Testosterone Nasal (Natesto) | 11mg TID | Male hypogonadism |

**Subtotal: 5 cards**

---

### Tier 4: Estrogen/Progestin Therapy

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_HRT_001 | Conjugated Estrogen (Premarin) | 0.3-1.25mg daily | Menopause symptoms, Osteoporosis |
| MED_ENDO_HRT_002 | Estradiol (Estrace, Vivelle) | 0.5-2mg daily or patch | Menopause symptoms |
| MED_ENDO_HRT_003 | Estradiol/Norethindrone (Activella) | Various daily | Menopause (with progestin) |
| MED_ENDO_HRT_004 | Medroxyprogesterone (Provera) | 2.5-10mg daily | HRT, Abnormal bleeding |
| MED_ENDO_HRT_005 | Progesterone (Prometrium) | 100-200mg daily | HRT, Luteal support |
| MED_ENDO_HRT_006 | Ospemifene (Osphena) | 60mg daily | Dyspareunia (menopause) |

**Subtotal: 6 cards**

---

### Tier 4: Other Hormonal Agents

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_HORMOTH_001 | Desmopressin (DDAVP) | 0.1-0.4mg daily | Diabetes insipidus, Enuresis |
| MED_ENDO_HORMOTH_002 | Cabergoline (Dostinex) | 0.25-1mg twice weekly | Prolactinoma |
| MED_ENDO_HORMOTH_003 | Bromocriptine (Parlodel) | 2.5-15mg daily | Prolactinoma, Parkinson's |

**Subtotal: 3 cards**

---

## MISCELLANEOUS MEDICATIONS

### Tier 4: Potassium & Electrolytes

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_LYTE_001 | Potassium Chloride (K-Dur, Klor-Con) | 10-40mEq daily | Hypokalemia |
| MED_ENDO_LYTE_002 | Sodium Bicarbonate | 325-2000mg daily | Metabolic acidosis, CKD |
| MED_ENDO_LYTE_003 | Sodium Polystyrene (Kayexalate) | 15-60g daily | Hyperkalemia |
| MED_ENDO_LYTE_004 | Patiromer (Veltassa) | 8.4-25.2g daily | Hyperkalemia (CKD) |
| MED_ENDO_LYTE_005 | Sodium Zirconium (Lokelma) | 5-15g daily | Hyperkalemia |

**Subtotal: 5 cards**

---

### Tier 4: CKD Medications

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_CKD_001 | Epoetin Alfa (Epogen, Procrit) | Variable SQ/IV | Anemia of CKD |
| MED_ENDO_CKD_002 | Darbepoetin (Aranesp) | Variable SQ/IV | Anemia of CKD |
| MED_ENDO_CKD_003 | Sevelamer (Renagel, Renvela) | 800-1600mg TID | Hyperphosphatemia |
| MED_ENDO_CKD_004 | Lanthanum (Fosrenol) | 500-1000mg TID | Hyperphosphatemia |
| MED_ENDO_CKD_005 | Calcitriol (Rocaltrol) | 0.25-1mcg daily | Secondary hyperparathyroidism |
| MED_ENDO_CKD_006 | Paricalcitol (Zemplar) | 1-4mcg daily | Secondary hyperparathyroidism |
| MED_ENDO_CKD_007 | Cinacalcet (Sensipar) | 30-180mg daily | Secondary hyperparathyroidism |

**Subtotal: 7 cards**

---

### Tier 4: Smoking Cessation

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_SMOKE_001 | Varenicline (Chantix) | 0.5-1mg BID | Smoking cessation |
| MED_ENDO_SMOKE_002 | Bupropion SR (Zyban) | 150mg BID | Smoking cessation |

**Subtotal: 2 cards**

---

### Tier 4: Phosphodiesterase-5 Inhibitors

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_PDE5_001 | Sildenafil (Viagra) | 25-100mg PRN | Erectile dysfunction |
| MED_ENDO_PDE5_002 | Tadalafil (Cialis) | 5-20mg PRN or daily | ED, BPH |
| MED_ENDO_PDE5_003 | Vardenafil (Levitra) | 5-20mg PRN | ED |
| MED_ENDO_PDE5_004 | Avanafil (Stendra) | 50-200mg PRN | ED |

**Subtotal: 4 cards**

---

### Tier 4: BPH Medications

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_ENDO_BPH_001 | Tamsulosin (Flomax) | 0.4mg daily | BPH (alpha blocker) |
| MED_ENDO_BPH_002 | Silodosin (Rapaflo) | 8mg daily | BPH (alpha blocker) |
| MED_ENDO_BPH_003 | Alfuzosin (Uroxatral) | 10mg daily | BPH (alpha blocker) |
| MED_ENDO_BPH_004 | Finasteride (Proscar) | 5mg daily | BPH (5-alpha reductase) |
| MED_ENDO_BPH_005 | Dutasteride (Avodart) | 0.5mg daily | BPH (5-alpha reductase) |

**Subtotal: 5 cards**

---

## Summary

| Tier 4 Category | Card Count |
|-----------------|------------|
| **THYROID MEDICATIONS** | |
| Hypothyroid Agents | 4 |
| Hyperthyroid Agents | 2 |
| **BONE HEALTH** | |
| Bisphosphonates | 4 |
| Other Bone Agents | 6 |
| **CORTICOSTEROIDS** | |
| Systemic Corticosteroids | 7 |
| **ALLERGY MEDICATIONS** | |
| Antihistamines (Rx) | 3 |
| Nasal Corticosteroids | 7 |
| **RHEUMATOLOGIC/IMMUNOLOGIC** | |
| DMARDs | 8 |
| Biologic DMARDs | 12 |
| Gout Medications | 5 |
| **HORMONAL AGENTS** | |
| Testosterone Replacement | 5 |
| Estrogen/Progestin Therapy | 6 |
| Other Hormonal | 3 |
| **MISCELLANEOUS** | |
| Potassium & Electrolytes | 5 |
| CKD Medications | 7 |
| Smoking Cessation | 2 |
| PDE5 Inhibitors | 4 |
| BPH Medications | 5 |
| **TOTAL** | **95 cards** |

---

## Card Naming Convention

**Format**: `MED_ENDO_[SUBCLASS]_[NUMBER]`

**Subclass Abbreviations**:
- `THY` = Thyroid (Hypothyroid)
- `HYPER` = Hyperthyroid
- `BONE` = Bisphosphonates
- `BONEOTH` = Other Bone Agents
- `STEROID` = Corticosteroids
- `ALLERGY` = Antihistamines (Rx)
- `NASAL` = Nasal Corticosteroids
- `DMARD` = DMARDs
- `BIODMARD` = Biologic DMARDs
- `GOUT` = Gout Medications
- `TEST` = Testosterone
- `HRT` = Hormone Replacement
- `HORMOTH` = Other Hormonal
- `LYTE` = Electrolytes
- `CKD` = CKD Medications
- `SMOKE` = Smoking Cessation
- `PDE5` = PDE5 Inhibitors
- `BPH` = BPH Medications

---

## Notes

1. **Cross-reference**: Many biologics used for multiple conditions (RA, IBD, psoriasis) - primary location here, use tags
2. **Methotrexate**: Also in oncology and dermatology - primary location in DMARDs for rheumatologic use
3. **Steroids**: Short courses vs chronic use have different safety profiles - include in card details
4. **Not included**: Contraceptives (separate family planning category), oncology medications

---

## Clinical Pearls for Card Development

1. **Levothyroxine Cards**: Include empty stomach timing, drug interactions, monitoring (TSH q6-8wks until stable)
2. **Bisphosphonate Cards**: Include administration instructions (upright, with water, wait 30min), jaw osteonecrosis risk
3. **Biologic DMARD Cards**: Include TB screening, infection monitoring, injection training
4. **Steroid Cards**: Include taper schedules, adrenal suppression risk, metabolic effects
5. **JAK Inhibitor Cards**: Include FDA warnings (VTE, CV, malignancy), infection monitoring
6. **Testosterone Cards**: Include PSA monitoring, hematocrit checks, fertility impact

---

*Version 1.0 | Created: 2024-11-23*
*Source: LIBRARY_TIER_STRUCTURE.md*
